Recently, Zuo et al. showed that low levels of expression of peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α) were associated with a poor prognosis in HCC and revealed the molecular mechanism of PGC1α in the metabolism and progression of HCC. Here, PPARGC1A is linked to hepatocellular carcinoma.